MEAD JOHNSON NUTRITION CO (MJN) Stock Price, Forecast & Analysis

USA • New York Stock Exchange • NYSE:MJN • US5828391061

89.98
-0.01 (-0.01%)
At close: Jun 14, 2017
90
+0.02 (+0.02%)
After Hours: 6/14/2017, 8:04:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

MJN Key Statistics, Chart & Performance

Key Statistics
Market Cap16.52B
Revenue(TTM)3.66B
Net Income(TTM)N/A
Shares183.64M
Float183.64M
52 Week High94.4
52 Week Low69.25
Yearly Dividend1.65
Dividend Yield1.83%
EPS(TTM)3.19
PE28.21
Fwd PE28.47
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
MJN short term performance overview.The bars show the price performance of MJN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20 25

MJN long term performance overview.The bars show the price performance of MJN in the last 1, 2 and 3 years. 1 year 2 years 3 years 1 2 3 4

The current stock price of MJN is 89.98 null. In the past month the price increased by 1.14%. In the past year, price increased by 4.39%.

MEAD JOHNSON NUTRITION CO / MJN Daily stock chart

MJN Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to MJN. When comparing the yearly performance of all stocks, MJN turns out to be only a medium performer in the overall market: it outperformed 57.91% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MJN Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to MJN. MJN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MJN Financial Highlights

Over the last trailing twelve months MJN reported a non-GAAP Earnings per Share(EPS) of 3.19. The EPS increased by 4.72% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.16%
ROA 14.95%
ROE -135.6%
Debt/Equity -6.3
Chartmill High Growth Momentum
EPS Q2Q%-17.07%
Sales Q2Q%N/A
EPS 1Y (TTM)4.72%
Revenue 1Y (TTM)N/A

MJN Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y-7.06%
Revenue Next YearN/A

MJN Ownership

Ownership
Inst Owners88.4%
Ins Owners0.04%
Short Float %N/A
Short RatioN/A

About MJN

Company Profile

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's `Enfa` family of brands, including Enfamil' infant formula, is the world's leading brand franchise in pediatric nutrition.

Company Info

MEAD JOHNSON NUTRITION CO

2701 PATRIOT BOULEVARD FOURTH FLOOR

GLENVIEW IL 60026

CEO: Peter Kasper Jakobsen

Phone: 847-832-2420

MEAD JOHNSON NUTRITION CO / MJN FAQ

What does MJN do?

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's `Enfa` family of brands, including Enfamil' infant formula, is the world's leading brand franchise in pediatric nutrition.


Can you provide the latest stock price for MEAD JOHNSON NUTRITION CO?

The current stock price of MJN is 89.98 null. The price decreased by -0.01% in the last trading session.


What is the dividend status of MEAD JOHNSON NUTRITION CO?

MEAD JOHNSON NUTRITION CO (MJN) has a dividend yield of 1.83%. The yearly dividend amount is currently 1.65.


How is the ChartMill rating for MEAD JOHNSON NUTRITION CO?

MJN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.